Clinical Trial Update: Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDS [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Behavioral Activation with armodafinil to treat fatigue in people with HIV infection and AIDS has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Human Immunodeficiency Virus Infection

Drugs mentioned

• Armodafinil (armodafinil)

Snippet

Sponsor: Research Foundation for Mental Hygiene, Inc. | Conditions: Hiv, Fatigue | Phase 4 | Status: COMPLETED